Two Biotech Executives Charged in Securities Fraud Scheme
Two former executives were recently indicted for schemes to defraud investors in CytoDyn, Inc. The executives, Nader Pourhassan,…
Author
CMS Releases OPPS and ASC Payment System Final Rule
The Centers for Medicare & Medicaid Services (CMS) on November 1, 2022, released the calendar year 2023 Hospital Outpatient…
Brand-Name Prescription Drug Prices Continue to Fall
In 2022, brand-name prescription drug prices fell for the fifth consecutive year, despite media coverage to the contrary. Even…
FDA Receives Increased Budget for FY 2023
The omnibus spending bill passed by Congress in December 2023 includes funding and direction for the United States Food and Drug…
Health Affairs Releases Research on Value-Based Payment Models
Health Affairs recently published a research brief, Value-Based Payment As A Tool To Address Excess US Health Spending. The brief…
DOJ and DEA Announce $1.9 Million Settlement, Resolving Controlled…
Northeast Hospital Corporation has agreed to pay $1.9 million in civil penalties to resolve allegations that the hospital failed…
CVS and Walgreens Reach Settlement in Opioid Lawsuits
CVS and Walgreens have reached a settlement totaling more than $10 billion, settling allegations that the companies failed to…
Diversity, Equity, and Inclusion (DEI) Educational Sessions at ACEHP Annual…
Starting February 6-9, 2023, the Alliance for Continuing Medical Education in the Health Professions (ACEHP) will hold its…
$3.1 Billion Walmart Opioid Settlement Reaches Important Milestone
Walmart recently announced that it reached settlement agreements with all fifty states – as well as Puerto Rico, Washington, DC,…
Congressional Report Released on FDA’s Improper Actions in Aduhelm Approval…
Following an 18-month investigation, House of Representatives Oversight and Reform Committee Chairwoman Carolyn Maloney and Energy…